Pedro Campaña Ávila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pedro Campaña Ávila has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
- Joshua Mark Galanter
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA
4 shared publications - Maria Pino-Yanes
Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna (ULL), La Laguna, Spain
4 shared publications Celeste Eng
Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA
3 shared publications- Denise Serebrisky
Jacobi Medical Center
3 shared publications - Esteban Gonzalez Burchard
University of California, San Francisco
3 shared publications - Harold J. Farber
Baylor College of Medicine, Houston, Texas; and
3 shared publications
Latest Publications
- 5 November 2020
- Published by JSTOR
- p. 99-114
COMENTARIO DE LA SENTENCIA DEL TRIBUNAL SUPREMO DE 11 DE SEPTIEMBRE DE 2019 (463/2019)
Igual que ya sucede desde hace años en las restantes Salas del Alto Tribunal, la Sala de lo Civil tomó la iniciativa en el año 2006 gracias al impulso del que e...
- 5 November 2020
- Published by JSTOR
- p. 99-114
COMENTARIO DE LA SENTENCIA DEL TRIBUNAL SUPREMO DE 11 DE SEPTIEMBRE DE 2019 (463/2019)
Igual que ya sucede desde hace años en las restantes Salas del Alto Tribunal, la Sala de lo Civil tomó la iniciativa en el año 2006 gracias al impulso del que e...
- Open Access
- 4 September 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-2
Author Correction: Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 4 September 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-2
Open AccessAuthor Correction: Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Open Access
- 20 February 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-13
Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations
Asthma is a complex disease with striking disparities across racial and ethnic groups. Despite its relatively high burden, representation of individuals of African ancestry in asthma genome-wide association studies (GWAS) has been inadequate, and true associations in these underrepresented minority groups have been inconclusive. We report the results of a genome-wide meta-analysis from the Consortium on Asthma among African Ancestry Populations (CAAPA; 7009 asthma cases, 7645 controls). We find strong evidence for association at four previously reported asthma loci whose discovery was driven largely by non-African populations, including the chromosome 17q12–q21 locus and the chr12q13 region, a novel (and not previously replicated) asthma locus recently identified by the Trans-National Asthma Genetic Consortium (TAGC). An additional seven loci reported by TAGC show marginal evidence for association in CAAPA. We also identify two novel loci (8p23 and 8q24) that may be specific to asthma risk in African ancestry populations.
- 20 February 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-13
Open AccessAssociation study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations
Asthma is a complex disease with striking disparities across racial and ethnic groups. Despite its relatively high burden, representation of individuals of African ancestry in asthma genome-wide association studies (GWAS) has been inadequate, and true associations in these underrepresented minority groups have been inconclusive. We report the results of a genome-wide meta-analysis from the Consortium on Asthma among African Ancestry Populations (CAAPA; 7009 asthma cases, 7645 controls). We find strong evidence for association at four previously reported asthma loci whose discovery was driven largely by non-African populations, including the chromosome 17q12–q21 locus and the chr12q13 region, a novel (and not previously replicated) asthma locus recently identified by the Trans-National Asthma Genetic Consortium (TAGC). An additional seven loci reported by TAGC show marginal evidence for association in CAAPA. We also identify two novel loci (8p23 and 8q24) that may be specific to asthma risk in African ancestry populations.
- 12 September 2018
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 19 (3) , 249-259
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma
Short-acting β2-adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the United States. However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma. To identify genetic variants that may contribute to differences in BDR in African Americans with asthma, we performed a genome-wide association study (GWAS) of BDR in 949 African-American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase III genotypes. We used linear regression models adjusting for age, sex, body mass index (BMI) and genetic ancestry to test for an association between BDR and genotype at single-nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1830 Latinos (total = 2779). Finally, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. We identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p = 7.69 × 10−9). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958 and rs7081864, p ≤ 5 × 10−8). Our results failed to replicate in three additional populations of 416 Latinos and 1615 African Americans. Our findings indicate that both population-specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups.
- 12 September 2018
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 19 (3) , 249-259
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma
Short-acting β2-adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the United States. However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma. To identify genetic variants that may contribute to differences in BDR in African Americans with asthma, we performed a genome-wide association study (GWAS) of BDR in 949 African-American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase III genotypes. We used linear regression models adjusting for age, sex, body mass index (BMI) and genetic ancestry to test for an association between BDR and genotype at single-nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1830 Latinos (total = 2779). Finally, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. We identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p = 7.69 × 10−9). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958 and rs7081864, p ≤ 5 × 10−8). Our results failed to replicate in three additional populations of 416 Latinos and 1615 African Americans. Our findings indicate that both population-specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups.
- Open Access
A Genome-wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma
Background: Short-acting B 2 -adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the U.S 1, 2 . However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma 3 Objective: To identify genetic variants that may contribute to differences in BDR in African Americans with asthma. Methods: We performed a genome-wide association study of BDR in 949 African American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase 3 genotypes. We used linear regression models adjusting for age, sex, body mass index and genetic ancestry to test for an association between BDR and genotype at single nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1,830 Latinos (Total=2,779). Lastly, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. Two additional populations of 416 Latinos and 1,325 African Americans were used to replicate significant associations. Results: We identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p=7.69 × 10 −9 ). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958, and rs7081864, p≤5 × 10 −8 ). Conclusions: Our findings indicate that both population specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups. Key messages: A GWAS for BDR in African American children with asthma identified an intergenic population specific variant at 9q21 to be associated with increased bronchodilator drug response (BDR). A meta-analysis of GWAS across African Americans and Latinos identified shared genetic variants at 10q21 in the intron of PRKG1 to be associated with differences in BDR. Further genetic studies need to be performed in diverse populations to identify the full set of genetic variants that contribute to BDR.
Open AccessA Genome-wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma
Background: Short-acting B 2 -adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the U.S 1, 2 . However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma 3 Objective: To identify genetic variants that may contribute to differences in BDR in African Americans with asthma. Methods: We performed a genome-wide association study of BDR in 949 African American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase 3 genotypes. We used linear regression models adjusting for age, sex, body mass index and genetic ancestry to test for an association between BDR and genotype at single nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1,830 Latinos (Total=2,779). Lastly, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. Two additional populations of 416 Latinos and 1,325 African Americans were used to replicate significant associations. Results: We identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p=7.69 × 10 −9 ). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958, and rs7081864, p≤5 × 10 −8 ). Conclusions: Our findings indicate that both population specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups. Key messages: A GWAS for BDR in African American children with asthma identified an intergenic population specific variant at 9q21 to be associated with increased bronchodilator drug response (BDR). A meta-analysis of GWAS across African Americans and Latinos identified shared genetic variants at 10q21 in the intron of PRKG1 to be associated with differences in BDR. Further genetic studies need to be performed in diverse populations to identify the full set of genetic variants that contribute to BDR.
- Open Access
- 1 February 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (2) , AB65
Clinical Characteristics of Aspirin Exacerbated Respiratory Disease in a Tertiary Care Patient Cohort
- 1 February 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (2) , AB65
Open AccessClinical Characteristics of Aspirin Exacerbated Respiratory Disease in a Tertiary Care Patient Cohort
- Open Access
- 1 February 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (2) , AB284
Unified Airway Theory: Association of Bronchiectasis and Chronic Rhinosinusitis
- 1 February 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (2) , AB284
Open AccessUnified Airway Theory: Association of Bronchiectasis and Chronic Rhinosinusitis
- 1 February 2015
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 135 (2) , AB109
Vitamin D Supplementation and the Risk of Colds in Patients with Asthma
- 1 February 2015
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 135 (2) , AB109
Vitamin D Supplementation and the Risk of Colds in Patients with Asthma
- Open Access
- 1 February 2014
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 133 (2) , AB81
Nocturnal Asthma In Latino Children Is Associated With Severe Disease and Allergenic Triggers (GALA II Study)
- 1 February 2014
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 133 (2) , AB81
Open AccessNocturnal Asthma In Latino Children Is Associated With Severe Disease and Allergenic Triggers (GALA II Study)